1-13 of 13
idelalisib
Close
Sort by
Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.
https://doi.org/10.1182/hematology.2019000032
Published: 2019
Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.
https://doi.org/10.1182/hematology.2019000367
Published: 2019
Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.
https://doi.org/10.1182/asheducation-2017.1.329
Published: 2017
Journal Articles

How should we sequence and combine novel therapies in CLL?

Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 346–353.
https://doi.org/10.1182/asheducation-2017.1.346
Published: 2017
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Sequencing of chronic lymphocytic leukemia therapies

Jacqueline C. Barrientos
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 128–136.
https://doi.org/10.1182/asheducation-2016.1.128
Published: 2016
Journal Articles

Novel agents in chronic lymphocytic leukemia

Nicole Lamanna, Susan O’Brien
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 137–145.
https://doi.org/10.1182/asheducation-2016.1.137
Published: 2016
Journal Articles

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 355–360.
https://doi.org/10.1182/asheducation-2015.1.355
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Management of prolymphocytic leukemia

Claire Dearden
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.
https://doi.org/10.1182/asheducation-2015.1.361
Published: 2015
Journal Articles

B-cell receptor pathway modulators in NHL

Kristie A. Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 82–91.
https://doi.org/10.1182/asheducation-2015.1.82
Published: 2015
Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.
https://doi.org/10.1182/asheducation-2014.1.125
Published: 2014
Journal Articles

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 88–96.
https://doi.org/10.1182/asheducation.V2012.1.88.3801172
Published: 2012